Jump to content
Powered by

Baden-Württemberg and its companies

Bioeconomy refers to the sustainable management of renewable natural resources, which is why there is no such thing as a bioeconomy industry in the traditional sense. However, there are companies in Baden-Württemberg that use biomass as raw material base and have already developed products and processes in their effort to act more sustainably

The energy producer badenova uses male corn plants to produce renewable natural gas (RNG). The company circumvents the food vs fuel conflict as the male plants are only used to pollinate female corn before being discarded. A company called TECNARO from Ilsfeld/Auenstein near Heilbronn has developed a technology that it uses to produce injection-mouldable plastics and fibrous materials from lignin. These materials are already being used in numerous products. The company fischerwerke has developed a wall plug that is partially produced from renewable resources. The wall plug is produced from two-component nylon, and one of the two components is produced from castor oil. Daimler AG's A-Class is equipped with an engine cover that is also produced with a plastic partially made from biological resources.

Companies not only face challenges relating to products, but also concerning innovative production processes. New methods and machines need to be developed in order to be able to use biomass sustainably on an industrial scale. This means that traditional sectors such as the mechanical engineering and plant construction sectors must be made aware and persuaded of the necessity and benefits of the bioeconomy.

BIOPRO Baden-Württemberg GmbH is specifically interested in contacting companies that are already involved in bioeconomic activities, as well as companies that wish to contribute to the development of this area. Our contact details can be found under "BIOPRO services – Contacts".

Company profiles

  • Article - 24/01/2019

    In Germany, around 1,500 tonnes of antibiotics per year are administered to humans and animals. As a result, more and more bacteria are developing resistance to common antibiotics. As part of HyReKA, a cooperative project funded by the BMBF, scientists led by Professor Thomas Schwartz from the KIT are investigating how antibiotic-resistant pathogens spread and how they can be prevented from doing so.

  • Article - 10/01/2019

    In the new gene technology report, the interdisciplinary working group of the Berlin-Brandenburg Academy of Sciences (BBAW) takes stock of gene technology developments in Germany during the past few decades, and discusses the societal, legal and ethical challenges associated with these technologies in the future. The report is highly topical due to the controversy surrounding the ruling of the European Court of Justice on CRISPR/Cas9 genome…

Company foundations in the bioeconomy field

  • Article - 24/01/2019

    In Germany, around 1,500 tonnes of antibiotics per year are administered to humans and animals. As a result, more and more bacteria are developing resistance to common antibiotics. As part of HyReKA, a cooperative project funded by the BMBF, scientists led by Professor Thomas Schwartz from the KIT are investigating how antibiotic-resistant pathogens spread and how they can be prevented from doing so.

  • Article - 10/01/2019

    In the new gene technology report, the interdisciplinary working group of the Berlin-Brandenburg Academy of Sciences (BBAW) takes stock of gene technology developments in Germany during the past few decades, and discusses the societal, legal and ethical challenges associated with these technologies in the future. The report is highly topical due to the controversy surrounding the ruling of the European Court of Justice on CRISPR/Cas9 genome…

News of bioeconomic companies

Website address: https://www.biooekonomie-bw.de/en/bw/stakeholders/companies